-
1
-
-
77951714425
-
Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients
-
Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O, et al. (2010) Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. Clin Cancer Res 16(9): 2646-55.
-
(2010)
Clin Cancer Res
, vol.16
, Issue.9
, pp. 2646-2655
-
-
Besser, M.J.1
Shapira-Frommer, R.2
Treves, A.J.3
Zippel, D.4
Itzhaki, O.5
-
2
-
-
0037174674
-
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
-
Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, et al. (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298(5594): 850-4.
-
(2002)
Science
, vol.298
, Issue.5594
, pp. 850-854
-
-
Dudley, M.E.1
Wunderlich, J.R.2
Robbins, P.F.3
Yang, J.C.4
Hwu, P.5
-
3
-
-
84871207055
-
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients
-
Radvanyi LG, Bernatchez C, Zhang M, Fox PS, Miller P, et al. (2012) Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin Cancer Res 18(24): 6758-70.
-
(2012)
Clin Cancer Res
, vol.18
, Issue.24
, pp. 6758-6770
-
-
Radvanyi, L.G.1
Bernatchez, C.2
Zhang, M.3
Fox, P.S.4
Miller, P.5
-
4
-
-
79960299888
-
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy
-
Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, et al. (2011) Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res 17(13): 4550-7.
-
(2011)
Clin Cancer Res
, vol.17
, Issue.13
, pp. 4550-4557
-
-
Rosenberg, S.A.1
Yang, J.C.2
Sherry, R.M.3
Kammula, U.S.4
Hughes, M.S.5
-
5
-
-
84855952269
-
Targeting metastatic melanoma
-
Flaherty KT, (2011) Targeting metastatic melanoma. Annu Rev Med 63: 171-83.
-
(2011)
Annu Rev Med
, vol.63
, pp. 171-183
-
-
Flaherty, K.T.1
-
6
-
-
84858758766
-
Adoptive immunotherapy for cancer: harnessing the T cell response
-
Restifo NP, Dudley ME, Rosenberg SA, (2012) Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12(4): 269-81.
-
(2012)
Nat Rev Immunol
, vol.12
, Issue.4
, pp. 269-281
-
-
Restifo, N.P.1
Dudley, M.E.2
Rosenberg, S.A.3
-
7
-
-
84859471907
-
Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook
-
Wu R, Forget MA, Chacon J, Bernatchez C, Haymaker C, et al. (2012) Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook. Cancer J 18(2): 160-75.
-
(2012)
Cancer J
, vol.18
, Issue.2
, pp. 160-175
-
-
Wu, R.1
Forget, M.A.2
Chacon, J.3
Bernatchez, C.4
Haymaker, C.5
-
8
-
-
73949086540
-
MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro
-
Li Y, Liu S, Hernandez J, Vence L, Hwu P, et al. (2010) MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro. J Immunol 184(1): 452-65.
-
(2010)
J Immunol
, vol.184
, Issue.1
, pp. 452-465
-
-
Li, Y.1
Liu, S.2
Hernandez, J.3
Vence, L.4
Hwu, P.5
-
9
-
-
11144241310
-
Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy
-
Powell DJ Jr, Dudley ME, Robbins PF, Rosenberg SA, (2005) Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy. Blood 105(1): 241-50.
-
(2005)
Blood
, vol.105
, Issue.1
, pp. 241-250
-
-
Powell Jr, D.J.1
Dudley, M.E.2
Robbins, P.F.3
Rosenberg, S.A.4
-
10
-
-
67449092903
-
Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients
-
Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O, et al. (2009) Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients. J Immunother 32(4): 415-23.
-
(2009)
J Immunother
, vol.32
, Issue.4
, pp. 415-423
-
-
Besser, M.J.1
Shapira-Frommer, R.2
Treves, A.J.3
Zippel, D.4
Itzhaki, O.5
-
11
-
-
11344251911
-
Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy
-
Zhou J, Dudley ME, Rosenberg SA, Robbins PF, (2005) Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy. J Immunother 28(1): 53-62.
-
(2005)
J Immunother
, vol.28
, Issue.1
, pp. 53-62
-
-
Zhou, J.1
Dudley, M.E.2
Rosenberg, S.A.3
Robbins, P.F.4
-
12
-
-
27744450650
-
Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy
-
Zhou J, Shen X, Huang J, Hodes RJ, Rosenberg SA, et al. (2005) Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J Immunol 175(10): 7046-52.
-
(2005)
J Immunol
, vol.175
, Issue.10
, pp. 7046-7052
-
-
Zhou, J.1
Shen, X.2
Huang, J.3
Hodes, R.J.4
Rosenberg, S.A.5
-
13
-
-
0037829421
-
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
-
Dudley ME, Wunderlich JR, Shelton TE, Even J, Rosenberg SA, (2003) Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother 26(4): 332-42.
-
(2003)
J Immunother
, vol.26
, Issue.4
, pp. 332-342
-
-
Dudley, M.E.1
Wunderlich, J.R.2
Shelton, T.E.3
Even, J.4
Rosenberg, S.A.5
-
14
-
-
79953041310
-
Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function
-
Hernandez-Chacon JA, Li Y, Wu RC, Bernatchez C, Wang Y, et al. (2011) Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function. J Immunother 34(3): 236-50.
-
(2011)
J Immunother
, vol.34
, Issue.3
, pp. 236-250
-
-
Hernandez-Chacon, J.A.1
Li, Y.2
Wu, R.C.3
Bernatchez, C.4
Wang, Y.5
-
15
-
-
62549160588
-
First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting
-
Molckovsky A Siu LL, (2008) First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting. J Hematol Oncol 1: 20.
-
(2008)
J Hematol Oncol
, vol.1
, pp. 20
-
-
Molckovsky, A.1
Siu, L.L.2
-
16
-
-
24344469675
-
A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells
-
He L, Hakimi J, Salha D, Miron I, Dunn P, et al. (2005) A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells. J Immunol Methods 304(1-2): 43-59.
-
(2005)
J Immunol Methods
, vol.304
, Issue.1-2
, pp. 43-59
-
-
He, L.1
Hakimi, J.2
Salha, D.3
Miron, I.4
Dunn, P.5
-
17
-
-
17644389199
-
TNF/TNFR family members in costimulation of T cell responses
-
Watts TH, (2005) TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23: 23-68.
-
(2005)
Annu Rev Immunol
, vol.23
, pp. 23-68
-
-
Watts, T.H.1
-
18
-
-
74549216531
-
Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells
-
Pipkin ME, Sacks JA, Cruz-Guilloty F, Lichtenheld MG, Bevan MJ, et al. (2010) Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32(1): 79-90.
-
(2010)
Immunity
, vol.32
, Issue.1
, pp. 79-90
-
-
Pipkin, M.E.1
Sacks, J.A.2
Cruz-Guilloty, F.3
Lichtenheld, M.G.4
Bevan, M.J.5
-
19
-
-
78651272579
-
Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes
-
Parish ST, Wu JE, Effros RB, (2010) Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes. J Clin Immunol 30(6): 798-805.
-
(2010)
J Clin Immunol
, vol.30
, Issue.6
, pp. 798-805
-
-
Parish, S.T.1
Wu, J.E.2
Effros, R.B.3
-
20
-
-
19344374856
-
Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion
-
Song J, So T, Cheng M, Tang X, Croft M, (2005) Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 22(5): 621-31.
-
(2005)
Immunity
, vol.22
, Issue.5
, pp. 621-631
-
-
Song, J.1
So, T.2
Cheng, M.3
Tang, X.4
Croft, M.5
-
21
-
-
80054867338
-
T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy
-
Snell LM, Lin GH, McPherson AJ, Moraes TJ, Watts TH, (2011) T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy. Immunol Rev 244(1): 197-217.
-
(2011)
Immunol Rev
, vol.244
, Issue.1
, pp. 197-217
-
-
Snell, L.M.1
Lin, G.H.2
McPherson, A.J.3
Moraes, T.J.4
Watts, T.H.5
-
22
-
-
0242611000
-
CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool
-
Hendriks J, Xiao Y, Borst J, (2003) CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J Exp Med 198(9): 1369-80.
-
(2003)
J Exp Med
, vol.198
, Issue.9
, pp. 1369-1380
-
-
Hendriks, J.1
Xiao, Y.2
Borst, J.3
-
23
-
-
74949120423
-
CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production
-
Peperzak V, Xiao Y, Veraar EA, Borst J, (2010) CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production. J Clin Invest 120(1): 168-78.
-
(2010)
J Clin Invest
, vol.120
, Issue.1
, pp. 168-178
-
-
Peperzak, V.1
Xiao, Y.2
Veraar, E.A.3
Borst, J.4
-
24
-
-
65349153714
-
Immune regulation by 4-1BB and 4-1BBL: complexities and challenges
-
Wang C, Lin GH, McPherson AJ, Watts TH, (2009) Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol Rev 229(1): 192-215.
-
(2009)
Immunol Rev
, vol.229
, Issue.1
, pp. 192-215
-
-
Wang, C.1
Lin, G.H.2
McPherson, A.J.3
Watts, T.H.4
-
25
-
-
77957325210
-
4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes
-
Sluijter BJ, van den Hout MF, Stam AG, Lougheed SM, Suhoski MM, et al. (2010) 4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes. Clin Immunol 137(2): 221-33.
-
(2010)
Clin Immunol
, vol.137
, Issue.2
, pp. 221-233
-
-
Sluijter, B.J.1
van den Hout, M.F.2
Stam, A.G.3
Lougheed, S.M.4
Suhoski, M.M.5
-
26
-
-
62549160588
-
First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American Society of Clinical Oncology meeting
-
Molckovsky A, Siu LL, (2008) First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American Society of Clinical Oncology meeting. J. Hematol Oncol 1: 20.
-
(2008)
J. Hematol Oncol
, vol.1
, pp. 20
-
-
Molckovsky, A.1
Siu, L.L.2
-
27
-
-
79956149133
-
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies
-
Singh H, Figliola MJ, Dawson MJ, Huls H, Olivares S, et al. (2011) Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies. Cancer Res 71(10): 3516-27.
-
(2011)
Cancer Res
, vol.71
, Issue.10
, pp. 3516-3527
-
-
Singh, H.1
Figliola, M.J.2
Dawson, M.J.3
Huls, H.4
Olivares, S.5
-
28
-
-
34247212403
-
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules
-
Suhoski MM, Golovina TN, Aqui NA, Tai VC, Varela-Rohena A, et al. (2007) Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Mol Ther 15(5): 981-8.
-
(2007)
Mol Ther
, vol.15
, Issue.5
, pp. 981-988
-
-
Suhoski, M.M.1
Golovina, T.N.2
Aqui, N.A.3
Tai, V.C.4
Varela-Rohena, A.5
-
29
-
-
79961133788
-
Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes
-
Ye Q, Loisiou M, Levine BL, Suhoski MM, Riley JL, et al. (2011) Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes. J Transl Med 9: 131.
-
(2011)
J Transl Med
, vol.9
, pp. 131
-
-
Ye, Q.1
Loisiou, M.2
Levine, B.L.3
Suhoski, M.M.4
Riley, J.L.5
-
30
-
-
20244366111
-
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
-
Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, et al. (2005) Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23(10): 2346-57.
-
(2005)
J Clin Oncol
, vol.23
, Issue.10
, pp. 2346-2357
-
-
Dudley, M.E.1
Wunderlich, J.R.2
Yang, J.C.3
Sherry, R.M.4
Topalian, S.L.5
-
31
-
-
17844381006
-
Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression
-
Huang J, Khong HT, Dudley ME, El-Gamil M, Li YF, et al. (2005) Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression. J Immunother 28(3): 258-67.
-
(2005)
J Immunother
, vol.28
, Issue.3
, pp. 258-267
-
-
Huang, J.1
Khong, H.T.2
Dudley, M.E.3
El-Gamil, M.4
Li, Y.F.5
-
32
-
-
84863618564
-
CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells
-
Ferrer IR, Wagener ME, Song M, Ford ML, (2012) CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells. PLoS One 7(7): e40559.
-
(2012)
PLoS One
, vol.7
, Issue.7
-
-
Ferrer, I.R.1
Wagener, M.E.2
Song, M.3
Ford, M.L.4
-
33
-
-
33644500140
-
IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival
-
Pulle G, Vidric M, Watts TH, (2006) IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival. J Immunol 176(5): 2739-48.
-
(2006)
J Immunol
, vol.176
, Issue.5
, pp. 2739-2748
-
-
Pulle, G.1
Vidric, M.2
Watts, T.H.3
-
34
-
-
0032374052
-
Role of 4-1BB in immune responses
-
Vinay DS Kwon BS, (1998) Role of 4-1BB in immune responses. Semin Immunol 10(6): 481-9.
-
(1998)
Semin Immunol
, vol.10
, Issue.6
, pp. 481-489
-
-
Vinay, D.S.1
Kwon, B.S.2
-
35
-
-
4644271443
-
CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection
-
Sun JC, Williams MA, Bevan MJ, (2004) CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol 5(9): 927-33.
-
(2004)
Nat Immunol
, vol.5
, Issue.9
, pp. 927-933
-
-
Sun, J.C.1
Williams, M.A.2
Bevan, M.J.3
|